Paul Johnson

Paul Johnson is an experienced executive currently serving as an Operating Partner at Ampersand Capital Partners since 2018 and as President and CEO of PHJ Consulting LLC since 2016. Johnson holds multiple board positions, including board member roles at Tjoapack, Phosphorex, Lil' Drug Store Products, and previously at MedPharm Ltd. Johnson's extensive background includes leadership roles such as CEO and President at DPT and Renaissance Pharmaceuticals from 2015 to 2016, and Group President and COO at DPT Laboratories from 2001 to 2014. Johnson earned an MBA from Southern Methodist University and a B.A. from The University of Texas at El Paso.